Ischemia–Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets
International Journal of Molecular Sciences · 14.04.2024 · 25 (8) · 4332
DOI: 10.3390/ijms25084332 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.04.2024. Verfasst von Francesco Lasorsa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision and Regenerative Medicine and Ionian Area-Urology, Andrology and Kidney Transplantation Unit, University of Bari "Aldo Moro",…. Hauptthemen laut MEDLINE: Reperfusion Injury, Kidney Transplantation. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kidney transplantation offers a longer life expectancy and a better quality of life than dialysis to patients with end-stage kidney disease. Ischemia–reperfusion injury (IRI) is thought to be a cornerstone in delayed or reduced graft function and increases the risk of rejection by triggering the immunogenicity of the organ. IRI is an unavoidable event that happens when the blood supply is temporarily reduced and then restored to an organ. IRI is the result of several biological pathways, such as transcriptional reprogramming, apoptosis and necrosis, innate and adaptive immune responses, and endothelial dysfunction. Tubular cells mostly depend on fatty acid (FA) β-oxidation for energy production since more ATP molecules are yielded per substrate molecule than glucose oxidation. Upon ischemia–reperfusion damage, the innate and adaptive immune system activates to achieve tissue clearance and repair. Several cells, cytokines, enzymes, receptors, and ligands are known to take part in these events. The complement cascade might start even before organ procurement in deceased donors. However, additional experimental and clinical data are required to better understand the pathogenic events that take place during this complex process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Precision and Regenerative Medicine and Ionian Area-Urology, Andrology and Kidney Transplantation Unit, University of Bari "Aldo Moro", 70124 Bari, Italy.
- Department of Precision and Regenerative Medicine and Ionian Area-Pathology Unit, University of Bari "Aldo Moro", 70124 Bari, Italy.
- Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, 80131 Naples, Italy.
- Department of Urology, University of L'Aquila, 67010 L'Aquila, Italy.
- Division of Urology, Department of Surgical Sciences, AORN Sant'Anna e San Sebastiano, 81100 Caserta, Italy.
- Division of Urology, European Institute of Oncology, IRCCS, 71013 Milan, Italy.
ORCID-Profile: Francesco Lasorsa, Antonio d'Amati, Felice Crocetto, Savio Domenico Pandolfo, Biagio Barone, Matteo Ferro, Pasquale Ditonno, Giuseppe Lucarelli
Zitieren
APA
Lasorsa, F., Rutigliano, M., Milella, M., d'Amati, A., Crocetto, F., Pandolfo, S. D., Barone, B., Ferro, M., Spilotros, M., Battaglia, M., Ditonno, P., & Lucarelli, G. (2024). Ischemia–Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets. International Journal of Molecular Sciences, 25(8), 4332. https://doi.org/10.3390/ijms25084332
Vancouver
Lasorsa F, Rutigliano M, Milella M, d'Amati A, Crocetto F, Pandolfo SD, et al. Ischemia–Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets. International Journal of Molecular Sciences. 2024;25(8):4332. doi:10.3390/ijms25084332
BibTeX
@article{Lasorsa2024,
author = {Lasorsa, Francesco and Rutigliano, Monica and Milella, Martina and d'Amati, Antonio and Crocetto, Felice and Pandolfo, Savio Domenico and Barone, Biagio and Ferro, Matteo and Spilotros, Marco and Battaglia, Michele and Ditonno, Pasquale and Lucarelli, Giuseppe},
title = {Ischemia–Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {8},
pages = {4332},
doi = {10.3390/ijms25084332}
}
EUVIMED